Selank

Selank is a synthetic peptide derived from a tuftsin fragment and studied in neurobehavioral, stress-response, immune, and gene-expression models.

Proposed mechanisms include modulation of GABAergic signaling, neurotrophic pathways, cytokine expression, and monoamine-related systems, but no single validated target explains all reported effects.

Limited human literature and broader preclinical research.

Level III, Limited human evidence

Many studies are small, regional, or difficult to independently replicate. Product standardization and modern clinical validation are limited.

Comprehensive human toxicology, interaction, reproductive, and long-term safety data are lacking.

No FDA-approved drug product; FDA has identified safety-information gaps for compounded Selank.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

• Selank, 10 mgLyophilized

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.